ProMIS Neurosciences names Ivana Rubino chief commercial officer

Bitget2026/10/06 11:05

ProMIS Neurosciences appointed Ivana Rubino as chief commercial officer, effective Oct. 5, 2026. Rubino most recently served at Biogen as vice president, global head of Alzheimer’s disease and multiple sclerosis medical. Earlier roles included senior leadership posts at Biogen across Alzheimer’s programs, with prior medical affairs and commercial roles at Roche. Rubino will lead commercial strategy and market preparation for PMN310, including market access planning and launch readiness. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProMIS Neurosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060705PRIMZONEFULLFEED9840064) on October 06, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ProMIS Neurosciences appointed Ivana Rubino as chief commercial officer, effective Oct. 5, 2026.
Rubino most recently served at Biogen as vice president, global head of Alzheimer’s disease and multiple sclerosis medical.
Earlier roles included senior leadership posts at Biogen across Alzheimer’s programs, with prior medical affairs and commercial roles at Roche.
Rubino will lead commercial strategy and market preparation for PMN310, including market access planning and launch readiness.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProMIS Neurosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060705PRIMZONEFULLFEED9840064) on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26